又一例“人工心脏”植入手术在合肥京东方医院完成

Core Viewpoint - The successful implantation of an "artificial heart" at Hefei BOE Hospital represents a significant advancement in treating end-stage heart failure, providing a new treatment option for patients who cannot undergo heart transplants [1][2]. Group 1: Technology and Procedure - The implanted "artificial heart" weighs only 90 grams and is made from new materials, functioning as a mechanical device that assists the heart by pumping blood from the ventricle into the aorta [1]. - The device consists of an internal blood pump and tubing connected to the heart, and an external controller and battery pack that allow patients to move freely [1]. - The patient who received the implant had a left ventricular ejection fraction (LVEF) of only 15%, significantly below the normal standard of 55%, due to dilated cardiomyopathy, a hereditary condition with no current cure [1]. Group 2: Clinical Impact and Collaboration - The implantation procedure was performed by a multidisciplinary team, including experts from cardiac surgery, cardiology, anesthesia, extracorporeal circulation, intensive care, and ultrasound, demonstrating effective collaboration and precision [1][2]. - This marks the second successful "artificial heart" implantation at Hefei BOE Hospital, which is enhancing its capabilities in multidisciplinary teamwork, precise treatment, and meticulous management to improve access to high-end medical resources for local and surrounding patients [2].